Publication | Closed Access
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
35
Citations
13
References
2018
Year
Lymphoid NeoplasiaSignal TransductionCell RegulationIntra-clonal BcrProficient Cll SubpopulationImmunologyCell DeathImmunotherapyMedicineCell BiologyCell SignalingTumor BiologyHigh Cd20 Levels
| Year | Citations | |
|---|---|---|
Page 1
Page 1